{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:01:04Z","timestamp":1784635264917,"version":"3.55.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000027","name":"Nation\u00d7al Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["P01 AA029541"],"award-info":[{"award-number":["P01 AA029541"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"Nation\u00d7al Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["K24 AA022586"],"award-info":[{"award-number":["K24 AA022586"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"Nation\u00d7al Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["K24AA031211"],"award-info":[{"award-number":["K24AA031211"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"Nation\u00d7al Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["U01 AA026223"],"award-info":[{"award-number":["U01 AA026223"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Despite the current effective antiretroviral therapy (ART) and viral suppression, depression remains the most prevalent mental health challenge among people with HIV (PWH) in Uganda and worldwide. This study examined the relationship between CD4 cell count and depressive symptoms among PWH on ART with viral suppression, and the potential modification effect of alcohol use on this relationship. We combined baseline data from two longitudinal studies (DIPT (NCT03492216) and ADEPTT (NCT03302299)) conducted between May 2017 and August 2021 across four health facilities in Southwestern Uganda. Eligible participants were adults with suppressed HIV viral load. Depressive symptoms were assessed using the Center for Epidemiologic Studies Depression (CESD) Scale (\u2265\u200916 considered significant). CD4\u2009+\u2009count was measured through blood tests, while alcohol use was measured using both the Alcohol Use Disorders Identification Test - Consumption (AUDIT-C) and the alcohol biomarker phosphatidylethanol (PEth), measured in dried blood spots. Multivariable mixed effects logistic regression models examined associations. Among 908 participants, 14.6% had depressive symptoms. The median CD4 count was 632 cells\/mm\u00b3 (IQR: 467.5-825.5), and 62.1% had high or very high-risk alcohol use. Overall, no significant association was found between CD4 count and depressive symptoms (aOR: 1.04; 95% CI: 0.97\u20131.12;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.26). Additionally, no evidence of effect modification by level of alcohol use (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.10) was found. The prevalence of depressive symptoms is high among PWH with viral suppression. Healthcare providers should assess and manage depression among this population. Further studies should also explore the causes of the depressive symptoms and develop targeted interventions.\n                  <\/jats:p>","DOI":"10.1007\/s10461-026-05214-2","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T09:57:24Z","timestamp":1784627844000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association Between Alcohol Use, CD4 Count, and Depressive Symptoms Among People with HIV with Viral Load Suppressed in Southwestern Uganda"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2739-1713","authenticated-orcid":false,"given":"Alain","family":"Favina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Fatch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sowmya R.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Chamie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie","family":"Muyindike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Adong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nneka I.","family":"Emenyonu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adah","family":"Tumwegamire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Ngabirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Kekibiina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marson","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Beesiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam W.","family":"Carrico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"5214_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-021-00583-w","author":"J Hoare","year":"2021","unstructured":"Hoare J, et al. Global systematic review of common mental health disorders in adults living with HIV. Curr HIV AIDS Rep. 2021. https:\/\/doi.org\/10.1007\/s11904-021-00583-w.","journal-title":"Curr HIV AIDS Rep"},{"issue":"11","key":"5214_CR2","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1080\/09540121.2023.2176428","volume":"35","author":"JC Chukwuorji","year":"2023","unstructured":"Chukwuorji JC, et al. Addressing the unmet mental health needs of people living with HIV: a scoping review of interventions in sub-Saharan Africa. AIDS Care. 2023;35(11):1677\u201390.","journal-title":"AIDS Care"},{"key":"5214_CR3","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1017\/gmh.2020.18","volume":"7","author":"AS Dessauvagie","year":"2020","unstructured":"Dessauvagie AS, et al. The prevalence of mental health problems in sub-Saharan adolescents living with HIV: a systematic review. Glob Mental Health. 2020;7:e29.","journal-title":"Glob Mental Health"},{"issue":"2","key":"5214_CR4","doi-asserted-by":"publisher","first-page":"e0002767","DOI":"10.1371\/journal.pgph.0002767","volume":"4","author":"DS Boakye","year":"2024","unstructured":"Boakye DS, et al. Mental health burden among females living with HIV and AIDS in sub-Saharan Africa: a systematic review. PLOS Glob Public Health. 2024;4(2):e0002767.","journal-title":"PLOS Glob Public Health"},{"key":"5214_CR5","unstructured":"UAC. Uganda Aids Commission: 2024 Uganda HIV and AIDS Factsheet: based on data ending 31st December 2023. 2024. https:\/\/drive.google.com\/file\/d\/1awjU7HeaheWFNhl1gDlKIcN7daKWJQ7s\/view Accessed 15 Sept 2024."},{"issue":"1","key":"5214_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-023-00567-3","volume":"20","author":"R Ndagire","year":"2023","unstructured":"Ndagire R, et al. HIV viral load suppression among people with mental disorders at two urban HIV clinics in Uganda: a parallel convergent mixed methods study using the social ecological model. AIDS Res Ther. 2023;20(1):68.","journal-title":"AIDS Res Ther"},{"issue":"12","key":"5214_CR7","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1080\/09540121.2016.1191601","volume":"28","author":"E Kinyanda","year":"2016","unstructured":"Kinyanda E, et al. Risk of major depressive disorder among older persons living in HIV-endemic central and southwestern Uganda. AIDS Care. 2016;28(12):1516\u201321.","journal-title":"AIDS Care"},{"key":"5214_CR8","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s10461-016-1575-7","volume":"21","author":"E Kinyanda","year":"2017","unstructured":"Kinyanda E, et al. Incidence and persistence of major depressive disorder among people living with HIV in Uganda. AIDS Behav. 2017;21:1641\u201354.","journal-title":"AIDS Behav"},{"key":"5214_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10461-014-0796-x","volume":"19","author":"C Psaros","year":"2015","unstructured":"Psaros C, et al. The factor structure and presentation of depression among HIV-positive adults in Uganda. AIDS Behav. 2015;19:27\u201333.","journal-title":"AIDS Behav"},{"key":"5214_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jad.2021.05.064","volume":"292","author":"J-H Pei","year":"2021","unstructured":"Pei J-H, et al. Prevalence of suicidal ideation, suicide attempt, and suicide plan among HIV\/AIDS: a systematic review and meta-analysis. J Affect Disord. 2021;292:295\u2013304.","journal-title":"J Affect Disord"},{"issue":"8","key":"5214_CR11","doi-asserted-by":"publisher","first-page":"e0181960","DOI":"10.1371\/journal.pone.0181960","volume":"12","author":"C Bernard","year":"2017","unstructured":"Bernard C, Dabis F, de Rekeneire N. Prevalence and factors associated with depression in people living with HIV in sub-Saharan Africa: a systematic review and meta-analysis. PLoS ONE. 2017;12(8):e0181960.","journal-title":"PLoS ONE"},{"issue":"8","key":"5214_CR12","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1080\/09540121.2014.880399","volume":"26","author":"T Taniguchi","year":"2014","unstructured":"Taniguchi T, et al. Depression severity is associated with increased risk behaviors and decreased CD4 cell counts. AIDS Care. 2014;26(8):1004\u201312.","journal-title":"AIDS Care"},{"key":"5214_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.psyneuen.2018.06.013","volume":"96","author":"M Bekhbat","year":"2018","unstructured":"Bekhbat M, et al. HIV and symptoms of depression are independently associated with impaired glucocorticoid signaling. Psychoneuroendocrinology. 2018;96:118\u201325.","journal-title":"Psychoneuroendocrinology"},{"key":"5214_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jad.2024.04.006","volume":"356","author":"H Xue","year":"2024","unstructured":"Xue H, Chen J, Fan W. Assessing the causal relationship between immune cell traits and depression by Mendelian randomization analysis. J Affect Disord. 2024;356:48\u201353.","journal-title":"J Affect Disord"},{"issue":"3","key":"5214_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11030220","volume":"11","author":"MA Alvarez-Mon","year":"2021","unstructured":"Alvarez-Mon MA, et al. Expansion of CD4 T lymphocytes expressing interleukin 17 and tumor necrosis factor in patients with major depressive disorder. J Personal Med. 2021;11(3): 220.","journal-title":"J Personal Med"},{"issue":"3","key":"5214_CR16","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/s41380-022-01919-7","volume":"28","author":"\u00c9M Foley","year":"2023","unstructured":"Foley \u00c9M, et al. Peripheral blood cellular immunophenotype in depression: a systematic review and meta-analysis. Mol Psychiatry. 2023;28(3):1004\u201319.","journal-title":"Mol Psychiatry"},{"key":"5214_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2023.1130938","volume":"17","author":"K Goodkin","year":"2023","unstructured":"Goodkin K, et al. The comorbidity of depression and neurocognitive disorder in persons with HIV infection: call for investigation and treatment. Front Cell Neurosci. 2023;17: 1130938.","journal-title":"Front Cell Neurosci"},{"key":"5214_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.658420","volume":"12","author":"J Zhao","year":"2021","unstructured":"Zhao J, et al. Mitochondrial functions are compromised in CD4 T cells from ART-controlled PLHIV. Front Immunol. 2021;12: 658420.","journal-title":"Front Immunol"},{"issue":"9","key":"5214_CR19","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1093\/jac\/dkw196","volume":"71","author":"F Palella Jr","year":"2016","unstructured":"Palella F Jr, et al. CD4 cell count at initiation of ART, long-term likelihood of achieving CD4\u2009>\u2009750 cells\/mm3 and mortality risk. J Antimicrob Chemother. 2016;71(9):2654\u201362.","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"5214_CR20","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1038\/s41380-022-01619-2","volume":"27","author":"A Mudra Rakshasa-Loots","year":"2022","unstructured":"Mudra Rakshasa-Loots A, et al. Neuroinflammation in HIV-associated depression: evidence and future perspectives. Mol Psychiatry. 2022;27(9):3619\u201332.","journal-title":"Mol Psychiatry"},{"issue":"3","key":"5214_CR21","doi-asserted-by":"publisher","first-page":"423","DOI":"10.4172\/2155-9899.1000423","volume":"7","author":"Y Rivera-Rivera","year":"2016","unstructured":"Rivera-Rivera Y, et al. Impact of depression and inflammation on the progression of HIV disease. J Clin Cell Immunol. 2016;7(3):423.","journal-title":"J Clin Cell Immunol"},{"issue":"3","key":"5214_CR22","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1007\/s10461-024-04571-0","volume":"29","author":"B Huang","year":"2025","unstructured":"Huang B, et al. Depressive symptoms and HIV viral suppression: a systematic review and meta-analysis. AIDS Behav. 2025;29(3):870\u201383.","journal-title":"AIDS Behav"},{"issue":"1\u20133","key":"5214_CR23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jad.2011.07.009","volume":"135","author":"E Nakimuli-Mpungu","year":"2011","unstructured":"Nakimuli-Mpungu E, et al. Prevalence and factors associated with depressive disorders in an HIV+ rural patient population in southern Uganda. J Affect Disord. 2011;135(1\u20133):160\u20137.","journal-title":"J Affect Disord"},{"issue":"11","key":"5214_CR24","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1097\/QAD.0000000000002937","volume":"35","author":"P Pathela","year":"2021","unstructured":"Pathela P, et al. Initiating antiretroviral treatment for newly diagnosed HIV patients in sexual health clinics greatly improves timeliness of viral suppression. AIDS. 2021;35(11):1805\u201312.","journal-title":"AIDS"},{"issue":"12","key":"5214_CR25","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1097\/QAD.0000000000003327","volume":"36","author":"B Zhao","year":"2022","unstructured":"Zhao B, et al. Antiretroviral therapy initiation within 7 and 8\u201330 days post-HIV diagnosis demonstrates similar benefits in resource-limited settings. Aids. 2022;36(12):1741\u20133.","journal-title":"Aids"},{"issue":"12","key":"5214_CR26","doi-asserted-by":"publisher","first-page":"pe1899","DOI":"10.1016\/S2214-109X(23)00436-9","volume":"11","author":"G Chamie","year":"2023","unstructured":"Chamie G, et al. Financial incentives for reduced alcohol use and increased isoniazid adherence during tuberculosis preventive therapy among people with HIV in Uganda: an open-label, factorial randomised controlled trial. Lancet Global Health. 2023;11(12):pe1899\u2013e1910.","journal-title":"Lancet Global Health"},{"key":"5214_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.103045","author":"WR Muyindike","year":"2025","unstructured":"Muyindike WR, et al. Alcohol use and HIV suppression after completion of financial incentives for alcohol abstinence and isoniazid adherence: a randomized controlled trial. EClinicalMedicine. 2025. https:\/\/doi.org\/10.1016\/j.eclinm.2024.103045.","journal-title":"EClinicalMedicine"},{"issue":"10","key":"5214_CR28","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1097\/QAD.0000000000003613","volume":"37","author":"JA Hahn","year":"2023","unstructured":"Hahn JA, et al. Safety and tolerability of isoniazid preventive therapy for tuberculosis for persons with HIV with and without alcohol use. Aids. 2023;37(10):1535\u201343.","journal-title":"Aids"},{"issue":"1","key":"5214_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05304-7","volume":"22","author":"S Lodi","year":"2021","unstructured":"Lodi S, et al. The Drinkers\u2019 Intervention to Prevent Tuberculosis (DIPT) trial among heavy drinkers living with HIV in Uganda: study protocol of a 2\u00d7 2 factorial trial. Trials. 2021;22(1):355.","journal-title":"Trials"},{"issue":"7","key":"5214_CR30","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1007\/s10461-020-03154-z","volume":"25","author":"JK Gunn","year":"2021","unstructured":"Gunn JK, et al. Understanding the risk of human immunodeficiency virus (HIV) virologic failure in the era of undetectable equals untransmittable. AIDS and Behavior. 2021;25(7):2259\u201365.","journal-title":"AIDS and Behavior"},{"issue":"3","key":"5214_CR31","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/014662167700100306","volume":"1","author":"LS Radloff","year":"1977","unstructured":"Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385\u2013401.","journal-title":"Appl Psychol Meas"},{"issue":"1","key":"5214_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-014-0303-y","volume":"14","author":"BK Natamba","year":"2014","unstructured":"Natamba BK, et al. Reliability and validity of the center for epidemiologic studies-depression scale in screening for depression among HIV-infected and-uninfected pregnant women attending antenatal services in northern Uganda: a cross-sectional study. BMC Psychiatry. 2014;14(1): 303.","journal-title":"BMC Psychiatry"},{"key":"5214_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-026-07803-w","author":"T Hamby","year":"2026","unstructured":"Hamby T, et al. A psychometric assessment of the factor structure and reliability of the Center for Epidemiological Studies Depression (CES-D) questionnaire in four African nations. BMC Psychiatry. 2026. https:\/\/doi.org\/10.1186\/s12888-026-07803-w.","journal-title":"BMC Psychiatry"},{"issue":"3","key":"5214_CR34","doi-asserted-by":"publisher","first-page":"e58067","DOI":"10.1371\/journal.pone.0058067","volume":"8","author":"RN Carleton","year":"2013","unstructured":"Carleton RN, et al. The center for epidemiologic studies depression scale: a review with a theoretical and empirical examination of item content and factor structure. PLoS ONE. 2013;8(3):e58067.","journal-title":"PLoS ONE"},{"key":"5214_CR35","unstructured":"Eaton WW, et al. Center for epidemiologic studies depression scale Review and revision. In: Maruish M, editor. The use of psychological testing for treatment planning and outcomes assessment. London: IEA Publishers; 2004."},{"key":"5214_CR36","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10461-012-0326-7","volume":"17","author":"BJ Feldman","year":"2013","unstructured":"Feldman BJ, et al. Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV. AIDS Behav. 2013;17:307\u201318.","journal-title":"AIDS Behav"},{"key":"5214_CR37","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1023\/A:1018451930750","volume":"6","author":"AW Wu","year":"1997","unstructured":"Wu AW, et al. Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Qual Life Res. 1997;6:481\u201393.","journal-title":"Qual Life Res"},{"key":"5214_CR38","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/j.1530-0277.2011.01669.x","volume":"36","author":"JA Hahn","year":"2012","unstructured":"Hahn JA, et al. Phosphatidylethanol (PEth) as a biomarker of alcohol consumption in HIV-positive patients in sub-Saharan Africa. Alcohol Clin Exp Res. 2012;36:854\u201362.","journal-title":"Alcohol Clin Exp Res"},{"issue":"7","key":"5214_CR39","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1111\/j.1530-0277.2007.00403.x","volume":"31","author":"KA Bradley","year":"2007","unstructured":"Bradley KA, et al. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res. 2007;31(7):1208\u201317.","journal-title":"Alcohol Clin Exp Res"},{"issue":"1\u20132","key":"5214_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.drugalcdep.2009.11.009","volume":"108","author":"AD Rubinsky","year":"2010","unstructured":"Rubinsky AD, et al. Estimating risk of alcohol dependence using alcohol screening scores. Drug Alcohol Depend. 2010;108(1\u20132):29\u201336.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"5214_CR41","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1039\/c0ay00636j","volume":"3","author":"J Jones","year":"2011","unstructured":"Jones J, et al. The detection of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanol in human dried blood spots. Anal Methods. 2011;3(5):1101\u20136.","journal-title":"Anal Methods"},{"issue":"5","key":"5214_CR42","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/QAI.0000000000001624","volume":"77","author":"JA Hahn","year":"2018","unstructured":"Hahn JA, et al. Alcohol use and HIV disease progression in an antiretroviral naive cohort. JAIDS J Acquir Immune Defic Syndr. 2018;77(5):492\u2013501.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"6","key":"5214_CR43","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1111\/1556-4029.13874","volume":"63","author":"W Ulwelling","year":"2018","unstructured":"Ulwelling W, Smith K. The PEth blood test in the security environment: what it is; why it is important; and interpretative guidelines. J Forensic Sci. 2018;63(6):1634\u201340.","journal-title":"J Forensic Sci"},{"key":"5214_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2025.112879","author":"JA Hahn","year":"2025","unstructured":"Hahn JA, et al. Alcohol interventions for persons with HIV: meta-analysis of randomized controlled trials using phosphatidylethanol and self-report. Drug Alcohol Depend. 2025. https:\/\/doi.org\/10.1016\/j.drugalcdep.2025.112879.","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"5214_CR45","doi-asserted-by":"publisher","first-page":"e0239087","DOI":"10.1371\/journal.pone.0239087","volume":"15","author":"R Opito","year":"2020","unstructured":"Opito R, et al. Treatment outcome of the implementation of HIV test and treat policy at The AIDs Support Organization (TASO) Tororo clinic, Eastern Uganda: a retrospective cohort study. PLoS ONE. 2020;15(9):e0239087.","journal-title":"PLoS ONE"},{"issue":"5","key":"5214_CR46","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1093\/jac\/dkz561","volume":"75","author":"D Ssemwanga","year":"2020","unstructured":"Ssemwanga D, et al. Prevalence of viral load suppression, predictors of virological failure and patterns of HIV drug resistance after 12 and 48 months on first-line antiretroviral therapy: a national cross-sectional survey in Uganda. J Antimicrob Chemother. 2020;75(5):1280\u20139.","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"5214_CR47","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/cid\/ciw125","volume":"62","author":"A Low","year":"2016","unstructured":"Low A, et al. Incidence of opportunistic infections and the impact of antiretroviral therapy among HIV-infected adults in low-and middle-income countries: a systematic review and meta-analysis. Clin Infect Dis. 2016;62(12):1595\u2013603.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"5214_CR48","doi-asserted-by":"publisher","DOI":"10.1177\/1557988320936892","volume":"14","author":"F Mhando","year":"2020","unstructured":"Mhando F, et al. Microfinance and peer health leadership intervention implementation for men in Dar es Salaam, Tanzania: a qualitative assessment of perceived economic and health outcomes. Am J Men\u2019s Health. 2020;14(4): 1557988320936892.","journal-title":"Am J Men's Health"},{"issue":"4","key":"5214_CR49","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2190\/PM.48.4.b","volume":"48","author":"VO Olisah","year":"2014","unstructured":"Olisah VO, Adekeye O, Sheikh TL. Depression and CD4 cell count among patients with HIV in a Nigerian University Teaching Hospital. Int J Psychiatry Med. 2014;48(4):253\u201361.","journal-title":"Int J Psychiatry Med"},{"key":"5214_CR50","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jad.2017.01.033","volume":"212","author":"E Kinyanda","year":"2017","unstructured":"Kinyanda E, et al. Major depressive disorder and suicidality in early HIV infection and its association with risk factors and negative outcomes as seen in semi-urban and rural Uganda. J Affect Disord. 2017;212:117\u201327.","journal-title":"J Affect Disord"},{"issue":"10","key":"5214_CR51","doi-asserted-by":"publisher","first-page":"e0276552","DOI":"10.1371\/journal.pone.0276552","volume":"17","author":"MM Kaggwa","year":"2022","unstructured":"Kaggwa MM, et al. Prevalence of depression in Uganda: a systematic review and meta-analysis. PLoS ONE. 2022;17(10):e0276552.","journal-title":"PLoS ONE"},{"key":"5214_CR52","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10461-014-0785-0","volume":"19","author":"BT Chan","year":"2015","unstructured":"Chan BT, et al. Declining prevalence of probable depression among patients presenting for antiretroviral therapy in rural Uganda: the role of early treatment initiation. AIDS Behav. 2015;19:19\u201326.","journal-title":"AIDS Behav"},{"issue":"4","key":"5214_CR53","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/bmjspcare-2019-001952","volume":"9","author":"S Rezaei","year":"2019","unstructured":"Rezaei S, et al. Global prevalence of depression in HIV\/AIDS: a systematic review and meta-analysis. BMJ Supp Palliat Care. 2019;9(4):404\u201312.","journal-title":"BMJ Supp Palliat Care"},{"issue":"5","key":"5214_CR54","doi-asserted-by":"publisher","first-page":"e0285310","DOI":"10.1371\/journal.pone.0285310","volume":"18","author":"GZ Rukundo","year":"2023","unstructured":"Rukundo GZ, et al. Depression, suicidality, substance-use and associated factors among people living with HIV the COVID-19 pandemic in Uganda. PLoS ONE. 2023;18(5):e0285310.","journal-title":"PLoS ONE"},{"issue":"2","key":"5214_CR55","doi-asserted-by":"publisher","first-page":"e0318120","DOI":"10.1371\/journal.pone.0318120","volume":"20","author":"FE Ghaimo","year":"2025","unstructured":"Ghaimo FE, et al. Prevalence and factors associated with alcohol use disorders among people living with HIV attending care and treatment centers at Kilimanjaro, Tanzania: a cross-sectional study. PLoS ONE. 2025;20(2):e0318120.","journal-title":"PLoS ONE"},{"issue":"2","key":"5214_CR56","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/09540121.2023.2285733","volume":"36","author":"Y Yang","year":"2024","unstructured":"Yang Y, et al. Global prevalence of depressive symptoms among people living with HIV\/AIDS: a systematic review and meta-analysis of the past five years. AIDS Care. 2024;36(2):153\u201364.","journal-title":"AIDS Care"},{"key":"5214_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-019-0240-3","author":"B Duko","year":"2019","unstructured":"Duko B, Ayalew M, Ayano G. The prevalence of alcohol use disorders among people living with HIV\/AIDS: a systematic review and meta-analysis. Subst Abuse Treat Prev Policy. 2019. https:\/\/doi.org\/10.1186\/s13011-019-0240-3.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"9","key":"5214_CR58","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/j.1360-0443.2008.02245.x","volume":"103","author":"LE Sullivan","year":"2008","unstructured":"Sullivan LE, et al. The impact of alcohol use on depressive symptoms in human immunodeficiency virus-infected patients. Addiction. 2008;103(9):1461\u20137.","journal-title":"Addiction"},{"issue":"2\u20133","key":"5214_CR59","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.drugalcdep.2011.01.014","volume":"117","author":"LE Sullivan","year":"2011","unstructured":"Sullivan LE, et al. Alcohol consumption and depressive symptoms over time: a longitudinal study of patients with and without HIV infection. Drug Alcoh Depend. 2011;117(2\u20133):158\u201363.","journal-title":"Drug Alcoh Depend"},{"key":"5214_CR60","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.drugalcdep.2013.09.014","volume":"134","author":"T Palfai","year":"2014","unstructured":"Palfai T, et al. The influence of depressive symptoms on alcohol use among HIV-infected Russian drinkers. Drug Alcoh Depend. 2014;134:85\u201391.","journal-title":"Drug Alcoh Depend"},{"key":"5214_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-020-2471-2","author":"J Ssebunnya","year":"2020","unstructured":"Ssebunnya J, et al. Social acceptance of alcohol use in Uganda. BMC Psychiatry. 2020. https:\/\/doi.org\/10.1186\/s12888-020-2471-2.","journal-title":"BMC Psychiatry"},{"issue":"1","key":"5214_CR62","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10461-012-0326-7","volume":"17","author":"BJ Feldman","year":"2013","unstructured":"Feldman BJ, et al. Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV. AIDS Behav. 2013;17(1):307\u201318.","journal-title":"AIDS Behav"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05214-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-026-05214-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05214-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:01:58Z","timestamp":1784631718000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-026-05214-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":62,"alternative-id":["5214"],"URL":"https:\/\/doi.org\/10.1007\/s10461-026-05214-2","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"10 June 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures conducted in the two studies included in this analysis were performed in accordance with the 2013 Declaration of Helsinki. Ethical approvals were obtained as described in the Methods section. Both studies involved human participants, and all of them provided written informed consent prior to enrolment.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}